US-tested Malaria vaccine protects adults for over one year

WASHINGTON, May 9 (KUNA) — A malaria vaccine has been proven to protect several healthy adults who have never caught the disease for more than one year, the US National Institutes of Health (NIH) said on Monday.
The trial saw 59 people out of a total 101 healthy 18-45 year-olds, who had never experienced the disease, handed the PfSPZ Vaccine, developed and produced by US firm Sanaria Inc.
All of the participants were exposed at varying times to the bites of Malaria mosquitoes.
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), which aided the tests, described the findings as “an encouraging step forward in our goal to control and ultimately eradicate malaria.” Malaria kills half a million people a year, most of them children. (end) sd

Related Post
تم تحديد موعد بدء المشروع، الذي يقع في الميدان، في أكتوبر 2017 ويتوقع انتهاؤه بحلول
DUBAI, Sept. 25, 2017 /PRNewswire/ — Vinson & Elkins continues to expand its Middle East disputes
SHENZHEN, China, Sept. 25, 2017 /PRNewswire/ — Mindray announced that its new-generation ventilator SV800 has